Abbott wins approval for hemoglobin test in Europe

05/13/2013 | RTT News

Abbott Laboratories has obtained CE mark approval to market its ARCHITECT clinical chemistry Hemoglobin A1c test in Europe. The blood assay, which measures an individual's average blood glucose level over the most recent three months, is intended to help doctors diagnose and monitor patients with diabetes, as well as identify those who may be at risk for developing the illness.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID